Stefan Yee

chairman and non – executive director

Mr. Stefan Yee has more than 30 years of experience in audit, corporate law, mergers and acquisitions, corporate finance.

Mr. Stefan Yee has more than 30 years of experience in audit, corporate law, mergers and acquisitions, corporate finance, investment banking and private equity with companies as KPMG, Linklaters, the Flemish investment bank Lessius, the Belgian Corporation for International Investment (SBI/BMI), Beluga (Euronext Brussels) and as the founder and CEO of the PE Group, a Belgian privately held private equity firm. Stefan is, and has been an investor and/or board member of several listed and private companies such as, amongst others, Beluga, Encare group (Mensura), AXI, The Reference, Alro Holdings, Loomans Group, United Brands, Capco, Faseas International (Spacewell), HD Partners (Dekabo group), AED Rent, UnifiedPost Group, NRG New Generation, Axiles Bionics, including several healthcare companies (Docpharma (formerly Euronext Brussels), Uteron Pharma and Imcyse). Stefan holds Masters degrees in Law and Business Management from the Universities of Brussels (VUB and ULB Solvay Business School) and the University of Chicago (as a BAEF Fellow).

Leon Van Rompay

non – executive director

Leon Van Rompay has more than 40 years’ experience in the pharmaceutical market. During his professional career he served in.

Leon Van Rompay has more than 40 years’ experience in the pharmaceutical market. During his professional career he served in several positions including country & area manager (covering major territories) and board member of the Zambon Group. He was founder and CEO of Docpharma, a Belgian based generics company that was listed on Euronext and served on different boards including Ecodis and Uteron Pharmaceuticals. He was a founding member of BIGE/IBES (Belgian Institute for Health and Economics), the B.G.A. (Belgian Generic Association), BAPIE (Belgian Association of Parallel Import and Export) and was an executive committee member and board member of the Belgian Pharmaceutical Industry Association. He also was a member of the pharmaceutical deontological commission and responsible for this commission in the industry association executive committee.

Marc Foidart

independent director

Marc Foidart obtained a Master in Business Engineering from the University of Liège (1998). He is co-founder of EKLO ASBL.

Marc Foidart obtained a Master in Business Engineering from the University of Liège (1998). He is co-founder of EKLO ASBL, Member of the Executive Committee of Noshaq SA in charge of the Life Sciences sector, CEO of B2H SA, the public company superseding the Liege life sciences ecosystem, and Investment Manager of Epimede SA, a EUR 50 million Belgian based private high-tech growth fund. He has more than 15 years of experience in strategic consulting and investment at all stages of development of small and medium high tech- high growth life sciences enterprises. He played a key role in several financing rounds at critical development stages of various Belgian young biotech companies among which: Mithra Pharmaceuticals SA, Imcyse SA, Uteron Pharma SA, PDC Line Pharma SA, Diagenode SA. As an entrepreneur, Marc Foidart is Co-Founder and past CEO of Arlenda SA, a spin-off company of the University of Liège providing expert statistical solutions to the pharmaceutical, chemical and environment industries. He is also Co-Founder and Executive Chairman of Eyed Pharma SA, a start-up company developing innovative controlled release microimplants in ophthalmology. Marc Foidart has been associate professor at the University of Liege since 2011.

Carolyn Myers

independent director

Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading health care.

Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading health care businesses. She is currently Principal of Bioensemble Ltd, a business strategy consulting firm that advises C-suite executives of small and medium size companies on a comprehensive range of drug development, commercial and business development services. Carolyn’s experience comes from having led many businesses in their growth strategies. At Allergan (formerly Actavis), she was the Vice President of Global Business Development and Alliance Management with a focus on expanding product portfolios. At Forest Laboratories (acquired by Actavis), Carolyn was the Vice President of the CNS marketing group responsible for marketing and sales of established and new products. At Mylan she held two different leadership positions including

President of Mylan Technologies, a division focused on developing generic transdermal systems and President of Dey Laboratories having full P&L responsibility to develop, manufacture and sell innovative respiratory products. Carolyn is also an advisor to several start-up organizations and capital investors.

Carolyn earned a PhD in Genetics from the University of British Columbia and an MBA from Rutgers University.

James Gale

independent director

James (Jim) Gale is the founding partner of Signet Healthcare Partners. Jim has over 30 years of healthcare investing and finance experience.

Jim is a Managing Director in Signet Fund IV and is currently the Chairman of the Board of Alpex Pharma S.A., Knight Therapeutics Inc. (TSX: GUD), Teligent (NSDQ: TLGT, formerly IGI Laboratories), and also serves on the Board of Directors of Bionpharma, Chr. Olesen Synthesis A/S, CoreRx, LeonNanodrugs GmbH, Pharmaceutics International (Pii), Advantice Health, and RK Pharma. Prior portfolio company boards include Arbor Pharmaceuticals, Amarin Corporation, eResearch Technologies Inc., and Valera Pharmaceuticals.

Prior to founding Signet, Jim was head of principal investment activities and head of investment banking for Gruntal & Co., LLC. While at Gruntal, he made a number of investments including Andrx Corporation, Royce Laboratories (merged with Watson Pharmaceuticals), Lifecell Corporation, Neurocrine Biosciences, and BML Pharmaceuticals (acquired by Endo Pharmaceuticals).

Chris Buyse

Independent Director

Chris Buyse has more than 30 years of international expertise across the healthcare sector.

Chris is currently Managing Director of Fund+, the largest Belgian life sciences-dedicated venture capital fund and serves as member of the board of directors of several European companies listed on Nasdaq and Euronext, including iTeos Therapeutics, Celyad and Inventiva Pharma. Chris is also a Director of the Francqui Foundation, among other private mandates. Chris holds a Master’s Degree in applied economic sciences from the University of Antwerp, and an MBA from the Vlerick School of Management in Ghent.

Stijn Van Rompay

chief executive officer & co-founder

Mr. Stijn Van Rompay has over 20 years of experience in leadership positions at various pharmaceutical companies.

Stijn co-founded and was the CEO of Alter Pharma, a pharmaceutical company focused on the development of complex generics and pharmacy-related product sales. He was also co-CEO of Uteron Pharma, a company focused on innovative female healthcare products.

Prior to these positions, Stijn was CFO and later, CEO of Docpharma (formerly quoted on Euronext Brussels) a generics and medical-device company. Under his leadership, the companies recorded strong growth and value creation. He also holds several non-executive director positions in the biotech sector, and acts as an advisor to venture capital investors. Stijn holds a Master’s degree in Applied Economics from the University of Antwerp.

Thomas Jacobsen

chief business development officer & co-founder

Mr. Thomas Jacobsen has over 20 years of experience in the pharmaceutical industry, with expertise in operational management, business development, licensing, and research and development.

He co-founded Alter Pharma, a pharmaceutical company focused on the development of complex generics and pharmacy-related product distribution. Prior to this, he worked with Docpharma, a generics and medical-device company that was acquired by Matrix Laboratories/Mylan Laboratories, where he worked on out-licensing of Docpharma’s products. Thomas started his career in the Scandinavian-based generics company Alternova, where he was responsible for licensing, product registration and launches. Thomas holds a Master’s Degree in Pharmacy from the University of Copenhagen and a Business Degree from Copenhagen Business School.

Jean-Luc Vandebroek

Chief Financial Officer

Jean-Luc Vandebroek is a seasoned executive who joined us in September 2021 from his role as CFO of Bone Therapeutics, a publicly traded biotech company based in Gosselies, Belgium. Prior to that, he was CFO and CIO at Alcopa and Fluxys, and before that, he held various senior financial positions at Delhaize Group. Jean-Luc is an experienced Executive Board member and has a track record of developing and implementing financing strategies and transactions and has a large, global network of investors and financial institutions. Jean-Luc holds a Master in Business Administration from the Louvain Management School.

Dietmar Aichhorn

chief operating officer

Dr. Dietmar Aichhorn, PhD, has over 20 years of experience in various scientific roles within the pharmaceutical industry.

Over the course of his career at Sandoz, Mylan, Innovacell, ViraTherapeutics and Polpharma Biologics, Dietmar has held several senior management positions of increasing responsibilities including Head Clinical Development and Head Development. Dr. Dietmar Aichhorn is an expert in the fields of technical development, clinical development and regulatory affairs in the US, EU and other key geographies. Most recently, Dietmar had an assignment at Polpharma Biologics, where he was responsible for the clinical development of monoclonal antibodies, as well as overseeing all scientific affairs. Dietmar graduated as chemical engineer in Linz but has perfected his project management skills at the university of Vienna.

Koenraad Van der Elst

chief legal officer

Mr. Koenraad Van der Elst has more than 30 years of experience as an in-house and external legal and general counsellor for various listed companies.

Koenraad served as General Counsel at Metris (currently Nikon Metrology), and acted as Secretary General & General Counsel of PUNCH INTERNATIONAL, a Belgian company listed on Euronext Brussels. He was also General Counsel & Secretary to the Board of PUNCH GRAPHIX plc, a company listed on the London Stock Exchange (AIM), and President of the Supervisory Board of PUNCH TECHNIX, a company listed on Euronext Amsterdam. Between 1995 and 2002, Koenraad was the Director of Legal Documentation at the Investment Banking Department (corporate finance & capital markets) of Generale Bank/Fortis Bank and was involved in most capital market transactions in Belgium (take-over bids, exchange offers, initial public offerings, etc.), as well as in a large number of corporate finance deals (M&A, advisory, fairness opinions, mergers, restructurings, etc.), at local, cross-border and international levels.

In addition, Koenraad was an assistant Professor at the University of Brussels (VUB) in Financial Law. He holds a law degree from the University of Brussels (VUB) and an MBA from EHSAL Brussels.

Grow with us

We are driven to continuously innovate existing medications and offer meaningful benefits to patients, physicians and payors.

Why join us

The key to success is an exceptional work force. Great people generate great results. As a young, entrepreneurial company, Hyloris fosters creativity, courage, and professionalism.
At Hyloris you will be part of multicultural and multidisciplinary team who will support you to further develop and grow your personal skills.

We strive to create an exciting and dynamic working environment in which you will be challenged to take initiative, contributing to the success of the company.

Interested in joining our mission to address important healthcare needs and deliver relevant improvements for patients, healthcare professionals and payors? Check out our vacancies below.

We look forward to hearing from you.

Latest vacancies

Clinical Project Manager

Location: Liège Belgium

view vacancy

We are currently looking for a Clinical Project Manager. The successful candidate will be responsible for the planning and management of clinical projects according to the clinical development plan, protocol, current GCP ICH guidelines, relevant laws and regulations.

Job description

As Clinical Project Manager, you will:

  • Contribute to the development of a Target Product Profile and required related clinical development strategy.
  • Deliver project development plans and estimated costs.
  • Ensure appropriate third-party provider selection, qualification and contracting for the assigned projects. (such as CROs, laboratory, monitors, etc.).
  • Ensure that the activities related to the assigned clinical project are coordinated effectively to ensure that the project is delivered in time, within the budget and within agreed project targets, while ensuring that quality standards are met.
  • Strong team leadership, actively managing the clinical project team assigned to the project(s).
  • Overseeing and monitoring the performance of the clinical vendors and CROs.
  • Ensure effective cross-functional teamwork during the start-up, execution and reporting of Clinical Projects. Including both internal and external services.
  • Overseeing and monitoring of project resource needs and collaborate with relevant partners to ensure ongoing and adequate resource allocation on the project.
  • Maintain and build relationships with Key Opinion Leaders. Attend and/or participate in Health or Clinical Research conferences.

Your professional profile

  • Minimum Qualification: MSc or PhD in in medical or life sciences (or equivalent required).
  • Minimum Experience: 5 years’ experience in Clinical Research.
  • Previous experience as Clinical Project Manager preferred.
  • Excellent knowledge of pharmaceutical product development process and requirements.
  • Excellent knowledge of GCP and ICH Guideline.
  • Experience with FDA regulations and guidelines on clinical development is an asset.
  • Languages: English (written and verbal) – French is an asset.
  • Computer proficiency is mandatory.

Your abilities

  • Strong interpersonal skills, a collaborative and trust enabling working style, building partnerships among key stakeholders.
  • Organizational aptitude to build, lead and develop an outstanding team.
  • Adaptability, flexibility, independence, and resourcefulness to both lead a big vision strategy while also willing to roll-up-sleeves and multi-task to thrive in a growing environment.
  • To have essential professional attributes include a detailed-oriented analytical thinking, a team-player attitude, respect and understanding for cultural differences in different countries, and efficient utilization of time and resources.

About Our Company

Hyloris is a specialty biopharma company focused on innovating, reinventing, and optimising existing medications to address important healthcare needs and deliver relevant improvements for patients, healthcare professionals and payors. Hyloris has built a broad, patented portfolio of 13 reformulated and repurposed value-added medicines that have the potential to offer significant advantages over available alternatives. Two products are currently in initial phases of commercialisation with partners: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a non-opioid post-operative pain treatment. The Company’s development strategy primarily focuses on the FDA’s 505(b)2 regulatory pathway, which is specifically designed for pharmaceuticals for which safety and efficacy of the molecule have already been established. This pathway can reduce the clinical burden required to bring a product to market, and significantly shorten the development timelines and reduce costs and risks. Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com and follow-us on LinkedIn.

Our values

Our talented staff work in accordance with our company values:

  • We are proud of our entrepreneurial culture and foster open communication, mutual respect, professionalism and efficient decision-making and we believe that our multicultural organisation is one of our most important competitive advantages.
  • We believe that timely and well considered decisions as a response to emerging opportunities and ideas is the key to our success.
  • We believe that the success of the company lies in the competence, dedication, and motivation of each of our employees.
  • We believe that freedom returns flexibility and empowerment returns commitment.

Download a PDF version HERE

Apply
Project Manager

Location: Liège Belgium

view vacancy

We are currently looking for a Project Manager. The successful candidate will be responsible for managing, coordinating, and delivering product development programs from an early-stage development phase until filing to Health Authorities, launch and routine commercial manufacturing.

Job description

In a matrix organization, as Project Manager, you will:

  • Work together with project team members and research scientists who would take on all scientific and technical matters in experimental study designs.
  • Prepare target product profiles, project development plans and budgets.
  • Prepare and keep up-to-date project timelines and costs and provide input for financial planning.
  • Organize efficient external and internal communication (periodic calls, ad-hoc calls, check lists, work specifications).
  • Co-ordinate external and internal project responsibilities against objectives and within budget.
  • Act as an internal or external point of contact with awareness of technical milestones and timelines as well as contractual obligations.
  • Assist with the preparation of requests for proposals and project proposals.
  • Monitor progress of individual projects, anticipate and manage risks and use or develop appropriate metrics as required.
  • Prepare stage-gate reports for e.g. project strategy, progress, issues, risks, updated timelines and costs.

Your professional profile

  • Minimum Qualification: MSc or PhD in Pharmacy, Chemistry or equivalent.
  • Minimum Experience: 7 years’ experience in pharmaceutical product development and project management.
  • Languages: English (written and verbal) – French is an asset.
  • Experienced Microsoft Project software user.
  • Ability to understand commercial contracts.

Your abilities

  • Demonstrate strong work ethics, and effective written and verbal communication skills.
  • Show an organizational aptitude to be part of an outstanding team.
  • Be flexible and have a strong team player attitude with the ability to motivate and to inject energy into the project teams.
  • Have strong interpersonal skills and a collaborative and trust enabling working style for building partnerships among key stakeholders.
  • Have the adaptability, flexibility, independence and resourcefulness to both lead a big vision strategy while also willing to roll-up-sleeves and multi-task to thrive in a growing environment.
  • Show respect for individuals and cultural difference across different countries.
  • Demonstrate efficient utilization of time and resources.
  • Be proactive and result-oriented with a focus on business.
  • Can steer external partners.

About Our Company

Hyloris is a specialty biopharma company focused on innovating, reinventing, and optimising existing medications to address important healthcare needs and deliver relevant improvements for patients, healthcare professionals and payors. Hyloris has built a broad, patented portfolio of 13 reformulated and repurposed value-added medicines that have the potential to offer significant advantages over available alternatives. Outside of its core strategic focus, the Company also has 3 high barrier generic products in development and registration phase. Two products are currently in initial phases of commercialisation with partners: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a non-opioid post-operative pain treatment. The Company’s development strategy primarily focuses on the FDA’s 505(b)2 regulatory pathway, which is specifically designed for pharmaceuticals for which safety and efficacy of the molecule have already been established. This pathway can reduce the clinical burden required to bring a product to market, and significantly shorten the development timelines and reduce costs and risks. Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com and follow-us on LinkedIn.

Our values

Our talented staff work in accordance with our company values:

  • We are proud of our entrepreneurial culture and foster open communication, mutual respect, professionalism and efficient decision-making and we believe that our multicultural organisation is one of our most important competitive advantages.
  • We believe that timely and well considered decisions as a response to emerging opportunities and ideas is the key to our success.
  • We believe that the success of the company lies in the competence, dedication, and motivation of each of our employees.
  • We believe that freedom returns flexibility and empowerment returns commitment.

Download a PDF version HERE

 

Apply
Business Analyst

Location: Liège Belgium

view vacancy

We are currently looking for a talented Business Analyst. The successful candidate must either have proven experience in data analysis and a background in the pharmaceutical industry or a healthcare degree, with strong analytical skills.

The job description

As Business Analyst, you will:

  • Provide our Business Development department with market analysis data and assist in the preparation of business cases and related tasks:
    • Perform market analysis for selected products using data as well as scientific literature to identify or evaluate new opportunities.
    • Perform analysis of prices, reimbursement, and market access in general.
    • Prepare business cases for new and existing products and maintain an updated overview of the available business cases.
    • Assist in monitoring and tracking of competitors and products (approvals, patent listings, market dynamics, etc.).
    • Assist in the preparation of commercial product presentations.
  • Identify new opportunities directly or through contact to universities, hospitals, and other partners.

Your professional profile

  • Strong educational background (Degree in Life Sciences or Business).
  • Entry level experience in the pharmaceutical industry. Previous experience with market and competition analysis is an asset.
  • Languages: English. French or Dutch is an asset.

Your abilities

  • Strong analytical skills.
  • Detail-oriented with the ability to work with big amount of data.
  • Excellent IT skills especially with Excel and Power Point, good understanding of analysis tools (pivot tables, charts etc).
  • Understanding the scientific principles.
  • Demonstrated ability to work in multidisciplinary teams.
  • Good self-starter, with ability to work independently.
  • Strong communication skills both oral and written.
  • Very good English skills (written and oral), French and/or other languages are an asset.
  • Capacity to react in unexpected situations and changing priorities.
  • Good understanding of and respect for cultural differences and the capacity to work effectively in a multicultural environment.

About our company

Hyloris is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients and the healthcare system. Hyloris applies its knowhow and technological innovations to existing pharmaceuticals and has built a broad proprietary product pipeline that has the potential to offer significant advantages over currently available alternatives. Hyloris currently has two partnered, commercial-stage products: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a non-opioid analgesic for the treatment of pain. The Company’s development strategy primarily focuses on the FDA’s 505(b)2 regulatory pathway, which is specifically designed for pharmaceuticals for which safety and efficacy of the molecule have already been established. This pathway can reduce the clinical burden required to bring a product to market, and significantly shorten the development timelines and reduce costs and risks. Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com and follow-us on LinkedIn.

Our values

Our talented staff work in accordance with our company values:

  • We are proud of our entrepreneurial culture and foster open communication, mutual respect, professionalism and efficient decision-making and we believe that our multicultural organisation is one of our most important competitive advantages.
  • We believe that timely and well considered decisions as a response to emerging opportunities and ideas is the key to our success.
  • We believe that the success of the company lies in the competence, dedication, and motivation of each of our employees.
  • We believe that freedom returns flexibility and empowerment returns commitment.

Download a PDF version HERE

Apply
Business Development Coordinator

Location: Liège Belgium

view vacancy

We are currently looking for a Business Development Coordinator. The successful candidate will be responsible for the coordination of activities that could potentially lead to the expansion of the company’s product portfolio. He/she will report into the Chief Business Development Officer.

Job description

As Business Development Coordinator, you will:

  • Build and maintain business cases, together with business analysts and our market access team.
  • Coordinate due diligence activities, with the support of R&D, regulatory, clinical, quality and finance departments.
  • Assist in licensing and partnering activities.
  • Maintain the company’s various business development databases.
  • Identify new development or licensing opportunities and partners, together with our business analysts.
  • Prepare business cases with the support of R&D, regulatory and clinical departments.
  • Build and maintain a competitor overview and coordinate input with business analysts (approvals, clinical trials, patent listings, market dynamics, etc.).
  • Build connections with KOLs, local focus groups and healthcare professionals together with business analysts, evaluate and bring new ideas.
  • Help business analysts to manage market surveys and analysis.
  • Manage calls and status reports of projects under evaluation.

Your professional profile

  • Minimum Qualification: MSc or higher in a life science discipline.
  • Minimum Experience: 5 years of experience in the pharmaceutical industry.
  • Languages: English (written and oral).

Your abilities

  • Communication and motivational skills.
  • Strong interpersonal skills with the ability to influence others in a positive and effective manner.
  • Demonstrated ability to contribute to a continuous learning and process improvement environment.
  • Strong commercial skills and abilities in negotiations.
  • Ability to manage teams in person and remotely.

About our company

Hyloris is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients and the healthcare system. Hyloris applies its knowhow and technological innovations to existing pharmaceuticals and has built a broad proprietary product pipeline that has the potential to offer significant advantages over currently available alternatives. Hyloris currently has two partnered, commercial-stage products: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a non-opioid analgesic for the treatment of pain. The Company’s development strategy primarily focuses on the FDA’s 505(b)2 regulatory pathway, which is specifically designed for pharmaceuticals for which safety and efficacy of the molecule have already been established. This pathway can reduce the clinical burden required to bring a product to market, and significantly shorten the development timelines and reduce costs and risks. Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com and follow-us on LinkedIn.

Our values

Our talented staff work in accordance with our company values:

  • We are proud of our entrepreneurial culture and foster open communication, mutual respect, professionalism and efficient decision-making and we believe that our multicultural organisation is one of our most important competitive advantages.
  • We believe that timely and well considered decisions as a response to emerging opportunities and ideas is the key to our success.
  • We believe that the success of the company lies in the competence, dedication, and motivation of each of our employees.
  • We believe that freedom returns flexibility and empowerment returns commitment.

Download a PDF version HERE

Apply